These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15848955)

  • 21. Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.
    Giles RV; Tidd DM
    Nucleic Acids Res; 1992 Feb; 20(4):763-70. PubMed ID: 1371864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity.
    Lima WF; Brown-Driver V; Fox M; Hanecak R; Bruice TW
    J Biol Chem; 1997 Jan; 272(1):626-38. PubMed ID: 8995306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides.
    Magner D; Biala E; Lisowiec-Wachnicka J; Kierzek E; Kierzek R
    PLoS One; 2015; 10(11):e0142139. PubMed ID: 26544037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. XRN2 is required for the degradation of target RNAs by RNase H1-dependent antisense oligonucleotides.
    Hori S; Yamamoto T; Obika S
    Biochem Biophys Res Commun; 2015 Aug; 464(2):506-11. PubMed ID: 26159921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes.
    Crooke ST; Lemonidis KM; Neilson L; Griffey R; Lesnik EA; Monia BP
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):599-608. PubMed ID: 8526876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides.
    Kandimalla ER; Manning A; Lathan C; Byrn RA; Agrawal S
    Nucleic Acids Res; 1995 Sep; 23(17):3578-84. PubMed ID: 7567472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational selection of antisense oligonucleotide sequences.
    Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
    Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the factors that contribute to on-target specificity of antisense oligonucleotides.
    Lima WF; Vickers TA; Nichols J; Li C; Crooke ST
    PLoS One; 2014; 9(7):e101752. PubMed ID: 25072142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
    Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
    Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense oligonucleotides made of 2'-O-alkylRNA: their properties and applications in RNA biochemistry.
    Lamond AI; Sproat BS
    FEBS Lett; 1993 Jun; 325(1-2):123-7. PubMed ID: 7685712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photochemically and chemically activatable antisense oligonucleotides: comparison of their reactivities towards DNA and RNA targets.
    Godard G; François JC; Duroux I; Asseline U; Chassignol M; Nguyen T; Hélène C; Saison-Behmoaras T
    Nucleic Acids Res; 1994 Nov; 22(22):4789-95. PubMed ID: 7527139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assay for evaluating ribonuclease H-mediated degradation of RNA-antisense oligonucleotide duplexes.
    Galarneau A; Min KL; Mangos MM; Damha MJ
    Methods Mol Biol; 2005; 288():65-80. PubMed ID: 15333898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligonucleotide scanning arrays: application to high-throughput screening for effective antisense reagents and the study of nucleic acid interactions.
    Sohail M; Southern EM
    Adv Biochem Eng Biotechnol; 2002; 77():43-56. PubMed ID: 12227736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
    Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
    Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term and long-term modulation of gene expression by antisense therapeutics.
    Sazani P; Vacek MM; Kole R
    Curr Opin Biotechnol; 2002 Oct; 13(5):468-72. PubMed ID: 12459339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morpholino antisense oligomers: the case for an RNase H-independent structural type.
    Summerton J
    Biochim Biophys Acta; 1999 Dec; 1489(1):141-58. PubMed ID: 10807004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): development of a new in vitro assay.
    Brukner I; Tremblay GA
    Biochemistry; 2000 Sep; 39(37):11463-6. PubMed ID: 10985792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.